Steroid-refractory Acute Graft-versus-host Disease(SR-aGVHD)
2 clinical trials · Condition
◉ Watch Steroid-refractory Acute Graft-versus-host Disease(SR-aGVHD)
| Record | Firm | Date |
|---|---|---|
| Managed Access Programs for INC424, Ruxolitinib (NCT04745637) | Novartis Pharmaceuticals |
Track Steroid-refractory Acute Graft-versus-host Disease(SR-aGVHD) automatically
Every clearance here is in the API, with alerts when new ones post.